Advertisement

Index by author

February 01, 1996; Volume 276,Issue 2

  1. Macleod, R J

    1. Effects of metabolites of leukotriene B4 on human neutrophil migration and cytosolic calcium levels.
      W S Powell, J Rokach, S P Khanapure, S Manna, M Hashefi, S Gravel, R J Macleod, J R Falck and R K Bhatt
      Journal of Pharmacology and Experimental Therapeutics February 1996, 276 (2) 728-736;

  2. Maeda, K

    1. Arbutin: mechanism of its depigmenting action in human melanocyte culture.
      K Maeda and M Fukuda
      Journal of Pharmacology and Experimental Therapeutics February 1996, 276 (2) 765-769;

  3. Magnuson, S R

    1. Pharmacological characterization of A-127722: an orally active and highly potent ETA-selective receptor antagonist.
      T J Opgenorth, A L Adler, S V Calzadilla, W J Chiou, B D Dayton, D B Dixon, L J Gehrke, L Hernandez, S R Magnuson, K C Marsh, E I Novosad, T W Von Geldern, J L Wessale, M Winn and J R Wu-Wong
      Journal of Pharmacology and Experimental Therapeutics February 1996, 276 (2) 473-481;

  4. Manna, S

    1. Effects of metabolites of leukotriene B4 on human neutrophil migration and cytosolic calcium levels.
      W S Powell, J Rokach, S P Khanapure, S Manna, M Hashefi, S Gravel, R J Macleod, J R Falck and R K Bhatt
      Journal of Pharmacology and Experimental Therapeutics February 1996, 276 (2) 728-736;

  5. Manning, C D

    1. Prolonged beta adrenoceptor stimulation up-regulates cAMP phosphodiesterase activity in human monocytes by increasing mRNA and protein for phosphodiesterases 4A and 4B.
      C D Manning, M M McLaughlin, G P Livi, L B Cieslinski, T J Torphy and M S Barnette
      Journal of Pharmacology and Experimental Therapeutics February 1996, 276 (2) 810-818;

  6. Markel, M L

    1. Urine acidification affects the activity of the organic base transporter in a nonstereoselective manner.
      M R Ujhelyi, M B Bottorff, M Schur, K Roll, H Zhang, J Stewart and M L Markel
      Journal of Pharmacology and Experimental Therapeutics February 1996, 276 (2) 683-689;

  7. Marsh, K C

    1. Pharmacological characterization of A-127722: an orally active and highly potent ETA-selective receptor antagonist.
      T J Opgenorth, A L Adler, S V Calzadilla, W J Chiou, B D Dayton, D B Dixon, L J Gehrke, L Hernandez, S R Magnuson, K C Marsh, E I Novosad, T W Von Geldern, J L Wessale, M Winn and J R Wu-Wong
      Journal of Pharmacology and Experimental Therapeutics February 1996, 276 (2) 473-481;

  8. Martin, B R

    1. Investigation of brain sites mediating cannabinoid-induced antinociception in rats: evidence supporting periaqueductal gray involvement.
      A H Lichtman, S A Cook and B R Martin
      Journal of Pharmacology and Experimental Therapeutics February 1996, 276 (2) 585-593;

  9. Martin, P L

    1. Characterization of 8-(N-methylisopropyl)amino-N6-(5'-endohydroxy- endonorbornyl)-9-methyladenine (WRC-0571), a highly potent and selective, non-xanthine antagonist of A1 adenosine receptors.
      P L Martin, R J Wysocki, R J Barrett, J M May and J Linden
      Journal of Pharmacology and Experimental Therapeutics February 1996, 276 (2) 490-499;

  10. Maslonek, K A

    1. Assessment of the involvement of central nervous system and peripheral opioid receptors in the immunomodulatory effects of acute morphine treatment in rats.
      K Fecho, K A Maslonek, L A Dykstra and D T Lysle
      Journal of Pharmacology and Experimental Therapeutics February 1996, 276 (2) 626-636;
« Previous (Pages : 1 2 3 ... 3) Next »
Back to top

In this issue

Advertisement